The Characterization of OXA-232 Carbapenemase-Producing ST437 Klebsiella pneumoniae in China
Open Access
- 8 July 2020
- journal article
- research article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2020, 1-5
Abstract
Carbapenem-resistant Klebsiella pneumoniae (CRKP) was epidemic around the world and become a global threat to public health. The most important carbapenem-resistant mechanism is producing carbapenemases, especially Klebsiella pneumoniae carbapenemase (KPC), which is prevalent in the international clonal complex CC11. The high-risk multidrug-resistant CC11 is widespread worldwide, and KPC-producing and (New Delhi metallo) NDM-producing strains had been reported in this clonal complex before; moreover, cases with the CC11 strain faced more severe forms of drug resistance and treatment challenges than other clonal complexes. In this study, we identified an OXA-232-producing ST437 Klebsiella pneumoniae isolate in China, which belonged to CC11. The isolate was resistant to β-lactams, aminoglycosides, and fluoroquinolones but susceptible to fosfomycin, tigecycline, and colistin. The blaOXA-232 gene was located on a 6141 bp ColKP3-type nonconjugative plasmid, and the plasmid was transformed by chemical transformation successfully. This is the first report of OXA-232-producing ST437 K. pneumoniae in China, a new clone of high-risk multidrug-resistant CC11.Keywords
Funding Information
- Key Research and Development Programme of Zhejiang (2015C03046, 8183009, 2019A610381, 2019C50087)
- National Natural Science Foundation of China (2015C03046, 8183009, 2019A610381, 2019C50087)
- Natural Science Foundation of Ningbo Municipality (2015C03046, 8183009, 2019A610381, 2019C50087)
- Ningbo Public Welfare Foundation (2015C03046, 8183009, 2019A610381, 2019C50087)
This publication has 26 references indexed in Scilit:
- Active surveillance and appropriate patient placement in contact isolation dramatically decreased carbapenem-resistant Enterobacterales infection and colonization in paediatric patients in ChinaJournal of Hospital Infection, 2020
- The Global Ascendency of OXA-48-Type CarbapenemasesClinical Microbiology Reviews, 2019
- New Delhi Metallo-β-Lactamase 5–Producing Klebsiella pneumoniae Sequence Type 258, Southwest China, 2017Emerging Infectious Diseases, 2019
- Emergence of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae That Carries a pLVPK-Like Virulence Plasmid among Elderly Patients in ChinaAntimicrobial Agents and Chemotherapy, 2019
- Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in NeonatesAntimicrobial Agents and Chemotherapy, 2017
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in ChinaEBioMedicine, 2017
- OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014Journal of Antimicrobial Chemotherapy, 2017
- Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383PLOS ONE, 2016
- Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from EnterobacteriaceaeInternational Journal of Antimicrobial Agents, 2013
- Emergence of Oxacillinase-Mediated Resistance to Imipenem inKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2004